NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品编号 06697999 持证商 SCHAPER & BRÜMMER GmbH & Co. KG 包装规格 100 St Packungsnorm N3 产品名 Esberitox Tabletten 剂型 Tabletten Pfl. Arzneimittel ja 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/produkt/esberitox-tabletten-100-st-06697999.html
产品名称:ISOPROTERENOL HYDROCHLORIDE上市时间:04/26/2023NDA/ANDA/BLA:211703持证商:HIKMANDC:说明书:批准信:
产品名称:GEFITINIB上市时间:04/26/2023NDA/ANDA/BLA:208913持证商:ACTAVIS LABS FL INCNDC:说明书:批准信:
产品名称:CLINDAMYCIN PHOSPHATE上市时间:04/26/2023NDA/ANDA/BLA:208767持证商:CADILANDC:68788-7990-6,72578-084-02,72578-084-03,53002-8371-1,70771-1414-2,70771-1414-3说明书:批准信:
产品名称:CLINDAMYCIN PHOSPHATE上市时间:04/26/2023NDA/ANDA/BLA:208767持证商:CADILANDC:68788-7990-6,72578-084-02,72578-084-03,53002-8371-1,70771-1414-2,70771-1414-3说明书:批准信:
产品名称:ZEJUL上市时间:04/26/2023NDA/ANDA/BLA:208447持证商:GLAXOSMITHKLINENDC:69656-103-30,69656-103-61说明书:httpS://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208447lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208447Orig1s000Ltr.pdf
产品名称:SPIRONOLACTONE上市时间:04/26/2023NDA/ANDA/BLA:205936持证商:ZYDUS PHARMSNDC:68382-660-10,68382-660-30,68382-661-10,68382-662-30,68382-662-06,70518-2384-0,70518-2384-2,70518-2385-0,70518-2386-0,68382-660-01,68382-661-06,68382-662-05,68382-662-16,0904-6927-61,51655-636-26,70771-1027-9,70771-1029-9,70518-...
产品名称:METAXALONE上市时间:04/26/2023NDA/ANDA/BLA:203695持证商:ACTAVIS LABS FL INCNDC:60760-093-60,60760-093-90,68788-7018-1,68788-7018-3,55700-911-90,68788-7018-0,45865-985-30,45865-985-90,50436-0449-1,50436-0449-2,50436-0449-3,80425-0131-2,0591-2341-01,60760-093-20,55700-911-30,80425-0131-3,63629-8014-1,636...
产品名称:VERSACLOZ上市时间:04/26/2023NDA/ANDA/BLA:203479持证商:TASMAN PHARMANDC:52817-601-38说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203479s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203479Orig1s000ltr.pdf
产品名称:CLOZAPINE上市时间:04/26/2023NDA/ANDA/BLA:203039持证商:TEVA PHARMS USANDC:0093-5376-01,0093-5376-84,0093-5377-01,0093-5377-84说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203039Orig1s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203039Orig1s000ltr.pdf
产品名称:DUTASTERIDE上市时间:04/26/2023NDA/ANDA/BLA:202660持证商:AUROBINDO PHARMA LTDNDC:59651-021-30,59651-021-90说明书:https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=b32611f3-50ec-45bb-a671-ea10cec7829d&type=pdf批准信: